Tumor Lysis Syndrome by A. Hong, K. Schlosser | OPENPediatrics
HTML-код
- Опубликовано: 20 июл 2024
- Dr. Andrew Hong outlines the basics of tumor lysis syndrome, key laboratory and clinical findings, and how to prevent and manage hyperuricemia and electrolyte abnormalities due to TLS. He also identifies risk-factors for this syndrome and guides the learner through two detailed cases.
Initial publication: December 17, 2020.
Please visit: www.openpediatrics.org
OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access-and thus at no expense to the user.
For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu
Please note: OPENPediatrics does not support nor control any related videos in the sidebar, these are placed by RUclips. We apologize for any inconvenience this may cause. Наука
OPENPediatrics thank you for breaking this down! Please continue to create more content like this.
To help prevent TLS, assess patients undergoing chemotherapy for risk factors at baseline and monitor them during and after the start of treatment as ordered. The mainstays of preventive care are hydration and allopurinol and recombinant urate oxidase (rasburicase).👍
love the explanation on this topic.... thank you
Thank you so much Dr. Hong and Open pediatrics- it was very, very well explained
I do love this!
Amazing lecture video❤
Open pediatrics 👍as good as always !!
Best
Hi. What is the best specific IV fluid for TLS? Thanks.
Probably just NS